CASI Pharmaceuticals, Inc. (CASI)

0.7651 -0.03 (-4.36%) USD  |  NASDAQ  |  Feb 20, 16:00
0.79 +0.02 (+3.25%) Pre-Market: 20:00
More

CASI Pharmaceuticals EV to Revenues

EV to Revenues Chart

View EV to Revenues for CASI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
Sinovac Biotech Ltd. --
Zai Lab Ltd. Upgrade
WuXi Biologics (Cayman), Inc. --
Viva Biotech Holdings --
Ascletis Pharma, Inc. Upgrade

EV to Revenues Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade